Skip to main content
Clinical Trials/PACTR202312489417172
PACTR202312489417172
Not yet recruiting
未知

Evaluating the effectiveness and cost-effectiveness of integrating mass drug administration for helminth control with seasonal malaria chemoprevention in Ghanaian children

ondon School of Hygiene Tropical Medicine0 sites1,200 target enrollmentDecember 4, 2023

Overview

Phase
未知
Intervention
Not specified
Conditions
Malaria
Sponsor
ondon School of Hygiene Tropical Medicine
Enrollment
1200
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 4, 2023
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
ondon School of Hygiene Tropical Medicine

Eligibility Criteria

Inclusion Criteria

  • Male and female children aged 1\-14 years;
  • Provision of written informed consent by the parent/caregiver and a positive assent by children aged \= 7 years (in line with legal regulations in Ghana);
  • Willingness to provide finger prick blood samples, urine, and stool samples;
  • Residence in the study area for at least the past six months and willingness to be available in the study area for follow\-up about 6 months after enrolment.

Exclusion Criteria

  • Acutely ill child at the time of the drug administration;
  • A child whose parents/care\-givers decline to provide consent;
  • A known HIV\-positive child receiving co\-trimoxazole prophylaxis;
  • A child who has received a dose of either Sulphadoxine\-pyrimethamine (SP), amodiaquine (AQ), albendazole (ALB) or praziquantel (PZQ) during the previous six months;
  • A child with a known allergy to any of SP, AQ, ALB, or PZQ

Outcomes

Primary Outcomes

Not specified

Similar Trials